«Three of the patients who had personalized
cancer treatment plans discussed at the Molecular Tumor board had a partial response,» said Richard Schwab, MD, Moores Cancer Center hematology oncologist and co-director of the Biorepository and Tissue Technology Shared Resource.
The cancer team at the University of Chicago Comprehensive Cancer Center is internationally recognized for expertise in designing
effective cancer treatment plans and developing clinical trials of new drugs.
The most recent IOM publication (released overnight) is a report on a workshop aimed at improving the quality of oncology care via patient -
centred cancer treatment planning.
In these cases, the value in the blood work is determining your pet's overall health as part of the diagnostic pathway and development of
a cancer treatment plan.